Lungs and Breathing
UMMC Interstitial Lung Disease Program
Interstitial Lung Disease (ILD) is a term used to describe a number of inflammatory and fibrotic diseases of the lungs. These conditions may be caused by environmental exposures, medications, autoimmune disease or genetics; however, the cause is often unknown.
Individuals with ILD might experience shortness of breath, fatigue, cough or edema. Treatment depends on the underlying condition and could include antifibrotics, immunosuppression or even lung transplant. UMMC is proud to be a Pulmonary Fibrosis Foundation Care Center Network Site and a founding member of the Foundation for Sarcoidosis Research (FSR) Global Sarcoidosis Clinic Alliance.
For appointments and referrals, call (601) 984-5650 or fax records to (601) 984-5658.
What to expect
Patients are usually referred by their primary care provider, rheumatologist or pulmonologist. Once at UMMC, patients with ILD will receive a timely, comprehensive evaluation. Cases are reviewed at our ILD Multidisciplinary Discussion, and an individualized plan of care is then recommended. Follow-up is provided either at UMMC or with referring providers as appropriate.
Program team
Mary Kendal Alias, RN, PFF, Care Center Coordinator
Kimberly Dobbs, MD, FCCP, Medical Director
Commonly treated conditions include:
- Idiopathic pulmonary fibrosis
- Hypersensitivity pneumonitis
- Connective tissue disease-ILD
- Sarcoidosis
- Lymphangioleiomyomatosis (LAM)
- Cryptogenic organizing pneumonia
- Cystic lung disease
- Smoking-related interstitial lung disease
- Pulmonary alveolar proteinosis
